Mereo BioPharma Group (LTS:0A9G) Change In Other Working Capital : $-0.67 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Mereo BioPharma Group Change In Other Working Capital?

Mereo BioPharma Group's Change In Other Working Capital for the quarter that ended in Mar. 2025 was $-0.17 Mil. It means Mereo BioPharma Group's Other Working Capital declined by $0.17 Mil from Dec. 2024 to Mar. 2025 .

Mereo BioPharma Group's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $-0.65 Mil. It means Mereo BioPharma Group's Other Working Capital declined by $0.65 Mil from Dec. 2023 to Dec. 2024 .

Mereo BioPharma Group Change In Other Working Capital Historical Data

The historical data trend for Mereo BioPharma Group's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mereo BioPharma Group Change In Other Working Capital Chart

Mereo BioPharma Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

-0.88

-0.58

-0.65

Mereo BioPharma Group Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Other Working Capital	Get a 7-Day Free Trial															-0.16	-0.16	-0.17	-0.17	-0.17

Mereo BioPharma Group Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.67 Mil.

Mereo BioPharma Group Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Mereo BioPharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (LTS:0A9G) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

MREO:USA MAH0:Germany MAH0:Germany

Address

One Cavendish Place, 4th Floor, London, GBR, W1G 0QF

Website

https://www.mereobiopharma.com

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Mereo BioPharma Group Headlines

No Headlines